TD Asset Management Inc Sells 45,915 Shares of The Cooper Companies, Inc. $COO

TD Asset Management Inc reduced its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 5.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 758,694 shares of the medical device company’s stock after selling 45,915 shares during the quarter. TD Asset Management Inc’s holdings in Cooper Companies were worth $52,016,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of COO. CYBER HORNET ETFs LLC bought a new stake in shares of Cooper Companies in the 2nd quarter valued at about $36,000. MUFG Securities EMEA plc bought a new stake in Cooper Companies in the second quarter valued at approximately $42,000. Assetmark Inc. lifted its position in Cooper Companies by 357.8% in the second quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock valued at $44,000 after purchasing an additional 483 shares during the last quarter. Quent Capital LLC purchased a new stake in shares of Cooper Companies during the third quarter valued at approximately $44,000. Finally, Mather Group LLC. bought a new stake in Cooper Companies during the 3rd quarter valued at $56,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Up 0.6%

COO opened at $84.01 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a 52 week low of $61.78 and a 52 week high of $92.84. The stock has a market cap of $16.39 billion, a PE ratio of 44.69, a PEG ratio of 2.38 and a beta of 1.03. The business has a 50 day moving average of $82.25 and a 200-day moving average of $75.61.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The company had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.04 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Cooper Companies news, insider Holly R. Sheffield purchased 1,230 shares of the stock in a transaction that occurred on Tuesday, December 16th. The stock was bought at an average cost of $80.75 per share, with a total value of $99,322.50. Following the transaction, the insider directly owned 39,052 shares in the company, valued at approximately $3,153,449. The trade was a 3.25% increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Lawrence Erik Kurzius acquired 2,000 shares of the business’s stock in a transaction on Wednesday, December 17th. The stock was acquired at an average price of $82.50 per share, for a total transaction of $165,000.00. Following the acquisition, the director owned 7,777 shares of the company’s stock, valued at approximately $641,602.50. This trade represents a 34.62% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased 16,014 shares of company stock worth $1,304,416 over the last 90 days. Corporate insiders own 1.98% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Morgan Stanley raised their price target on shares of Cooper Companies from $76.00 to $83.00 and gave the stock an “equal weight” rating in a report on Monday, December 8th. Mizuho set a $100.00 price target on Cooper Companies and gave the company an “outperform” rating in a report on Friday, December 5th. Robert W. Baird upped their price target on Cooper Companies from $85.00 to $98.00 and gave the company an “outperform” rating in a research report on Friday, December 5th. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, December 5th. Finally, Barclays set a $98.00 target price on Cooper Companies and gave the company an “overweight” rating in a report on Monday, January 26th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and a consensus target price of $90.77.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.